Provider of genome engineering solutions.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Synthego is a leading provider of genome engineering solutions. Synthego’s vision is to bring precision and automation to genome engineering, enabling rapid and cost-effective research with consistent results for every scientist.
Synthego Corp Funding
Sign up to gain insights into Synthego Corp funding history, including the funding round, time period, and amount raised.
| Financing Round | Date | Amount | Price per share | Valuation |
|---|---|---|---|---|
| Round | Date | Amount | PPS | Valuation |
| Series E | Dec 31, 2021 | 135M | ||
| Series D | Jun 11, 2020 | 100M | ||
| Series C | Oct 09, 2018 | 106M | ||
| Series B | Dec 21, 2016 | 41M | ||
| Series A | Jun 26, 2013 | 8M |
Access the PPS, Valuation details, and a wealth of other data by signing up. Source: Nasdaq Private Market
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Synthego Corp Management Team
Investors
Intel Capital Corp
Wellington Management Company
Logos Capital
Moore Strategic Ventures
Menlo Ventures
Perceptive Advisors
Gigafund
Chimera Partners
8VC
Declaration Partners
WI Harper Group Inc
Laurion Capital Management
SoftBank
Founders Fund
RA Capital Management
Synthego Corp Valuations & Financials
View real-time NPM data on Synthego Corp stock including daily Synthego Corp stock price estimates, valuation history, and historical share price information. Access Synthego Corp financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Synthego Corp pricing across six independent market signals. Looking for private company due diligence data sources on Synthego Corp? Get in touch to learn more.
Similar Companies
like Synthego Corp
Color
Healthcare & Life Sciences
Physician-ordered genetic testing with comprehensive support, utilizing advanced software and a certified laboratory.
Cityblock
Healthcare & Life Sciences
Tech-driven care provider for communities with complex needs.
Elligo Health Research
Healthcare & Life Sciences
Connects healthcare sites, sponsors, and patients to streamline clinical trial access through technology and data-driven solutions.
Benchling
Healthcare & Life Sciences
Cloud based platform for research and development in biotechnology.
OpenEvidence
Healthcare & Life Sciences
Empowers clinicians who seek evidence‑based insights by delivering AI‑summarized medical research at the point of care.
Kallyope
Healthcare & Life Sciences
Biotech company developing therapies targeting gut-brain axis interactions to treat metabolic and neurological diseases.
Evidation Health
Healthcare & Life Sciences
Digital health measurement and engagement platform.
Owkin
Healthcare & Life Sciences
Biotechnology company using AI to personalize treatment.
FAQ
We have answers
Synthego Corp stock does not trade on public stock exchanges. Synthego Corp stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Synthego Corp stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Synthego Corp Stock does not trade on public stock exchanges. In order to sell Synthego Corp shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Synthego Corp does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Synthego Corp share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Synthego Corp stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Synthego Corp stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Synthego Corp stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Synthego Corp is a private company and has not had an IPO. There is currently no Synthego Corp IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Synthego Corp IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
